Headquarters : Orexo AB, P.O. Box 303, 751 05 Uppsala, Sweden Visiting Address : Rapsgatan 7E, Uppsala, Sweden E-mail: info@orexo.com Phone: +46 (0)18 780 88 00 VAT NO. : SE556500-060001 Website : www.orexo.com Subsidiary The United States of America Orexo US Inc., 150 Headquarters Plaza, East Tower, Morristown, New Jersey 07960, United States E-mail: info-us@orexo.com Phone: +1 (0)855 982 7658 Medical Inquiries/ Adverse Events/ Product Complaints : 1-888-982-7658 (8:00am to 5:30pm ET) or 1-913-339-8424 after-hours Orexo is a pharmaceutical company based in Uppsala, Sweden initially financed with venture capital provided by HealthCap. Orexo develops improved pharmaceuticals and digital therapies addressing unmet needs within the growing space of mental illness and addiction disorders. The products are commercialized by Orexo in the US or via partners worldwide.